Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

21.60
-0.0800-0.37%
Post-market: 21.600.00000.00%19:30 EDT
Volume:376.56K
Turnover:8.16M
Market Cap:918.82M
PE:12.80
High:22.20
Open:21.64
Low:21.44
Close:21.68
52wk High:31.26
52wk Low:16.65
Shares:42.54M
Float Shares:30.52M
Volume Ratio:0.94
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.69
EPS(LYR):2.03
ROE:10.30%
ROA:5.11%
PB:1.20
PE(LYR):10.64

Loading ...

BRIEF-FDA Broadens Access To Over-The-Counter Naloxone Nasal Spray For Opioid Overdose

Reuters
·
Jun 16

FDA: Approved Otc Intranasal Naloxone Product, Rextovy, a 4 Mg Naloxone Hydrochloride Nasal Spray for Emergency Treatment of Opioid Overdose

THOMSON REUTERS
·
Jun 16

Amphastar Pharmaceuticals holds annual shareholder meeting

Reuters
·
Jun 04

Amphastar Pharmaceuticals Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Jun 03

Amphastar price target lowered to $20 from $23 at Barclays

TIPRANKS
·
Jun 03

Amphastar posts Jefferies healthcare conference deck highlighting pipeline shift toward proprietary drugs and biosimilars

Reuters
·
Jun 03

Amphastar CFO Bill Peters presents at Jefferies Healthcare Conference

Reuters
·
May 27

Wells Fargo Downgrades Amphastar Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $19 From $30

MT Newswires Live
·
May 14

Amphastar Pharmaceuticals Price Target Cut to $21.00/Share From $25.00 by Piper Sandler

Dow Jones
·
May 12

Amphastar price target lowered to $21 from $25 at Piper Sandler

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

Amphastar Pharmaceuticals, Inc : Piper Sandler Cuts Target Price to $21 From $25

THOMSON REUTERS
·
May 11

Amphastar cut to Hold at Needham after ‘disappointing’ results

TIPRANKS
·
May 09

Stock Track | Amphastar Pharmaceuticals Plummets 22.72% Intraday on Q1 Earnings Miss, Lower Prices, Higher Costs and Analyst Downgrade

Stock Track
·
May 08

Amphastar Pharmaceuticals Cut to Hold From Buy by Needham

Dow Jones
·
May 08

Needham downgrades Amphastar Pharmaceuticals (AMPH) to a Hold

TIPRANKS
·
May 08

Stock Track | Amphastar Pharmaceuticals Plunges 12.28% in Pre-Market on Q1 Earnings Miss, Lower Prices and Higher Costs

Stock Track
·
May 08

Stock Track | Amphastar Pharmaceuticals Plunges 13.03% on Q1 Earnings Miss, Lower Prices and Higher Costs

Stock Track
·
May 08

Amphastar Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Stock Track | Amphastar Pharmaceuticals Plunges 8.24% After-Hours on Q1 Earnings Miss, Lower Prices and Higher Costs

Stock Track
·
May 08